[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 771
Citations 0
Comment & Response
June 4, 2014

Guidelines for Cardiovascular Risk Assessment and Cholesterol Treatment—Reply

Author Affiliations
  • 1Stanford Prevention Research Center, Stanford, California
JAMA. 2014;311(21):2235-2236. doi:10.1001/jama.2014.4075

In Reply Dr Lloyd-Jones and colleagues clarify that the preferences of patients should be taken into account and that the guidelines on the use of statins should not be seen as mandates. However, given the credentials of the guideline panelists and the strong established tradition of the American College of Cardiology/American Heart Association (ACC/AHA) in generating highly influential guidelines, these documents end up being stronger than any absolute mandate. The intense conforming pressure that these guidelines exert on patients and clinicians1 cannot be underestimated.

First Page Preview View Large
First page PDF preview
First page PDF preview
×